To cite this paper use one of the standards below:
Ruthenium(II) complexes have been extensively investigated for their promising antitumor properties, particularly as nitric oxide (NO)-donor compounds. These complexes enable controlled NO release upon reduction or light irradiation, contributing to the modulation of biological responses associated with cancer therapy. More recently, ultrasound (US) has emerged as a potential stimulus for NO release through sonochemical effects induced by acoustic cavitation, which generate reactive species and promote redox processes. In parallel, sonodynamic therapy (SDT) has attracted increasing attention as a non-invasive therapeutic strategy capable of activating sensitizers at clinically relevant tissue depths. In this context, carbon dots (CDs) have emerged as attractive fluorescent nanomaterials owing to their excellent photophysical properties, high biocompatibility, and low-cost synthesis, making them suitable for bioimaging and theranostic applications in complex biological models, including three-dimensional (3D) cell cultures.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper